Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel Moore, MD
Type 1 Diabetes TrialNet
Study Chair - Kevan Herold, MD
Type 1 Diabetes TrialNet Chairman
Study Director - Stephen Gitelman, MD
Type 1 Diabetes TrialNet
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Queensland Children'S Hospital
South Brisbane, Queensland, Australia
- Walter and Eliza Hall Institute of Medical Research
Melbourne, Victoria, Australia
- Childrens Hospital of Orange County
Orange, California, United States
- Stanford University
Palo Alto, California, United States
- University of California San Francisco
San Francisco, California, United States
- Barbara Davis Center for Childhood Diabetes
Aurora, Colorado, United States
- Yale University
New Haven, Connecticut, United States
- University of Florida
Gainesville, Florida, United States
- University of Miami
Maimi, Florida, United States
- Indiana University - Riley Hospital for Children
Indianapolis, Indiana, United States
- the Children'S Mercy Hospital
Kansas City, Kansas, United States
- Joslin Diabetes Center
Boston, Massachusetts, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- Columbia University
New York, New York, United States
- University of Pittsburg
Pittsburgh, Pennsylvania, United States
- Sanford Children'S Specialty Clinic
Sioux Falls, South Dakota, United States
- Vanderbilt Eskind Diabetes Center
Nashville, Tennessee, United States
- University of Texas Southwestern
Dallas, Texas, United States
- Benaroya Research Institute
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Oct 2023
- Primary completion
- 31 Mar 2027
- Completion
- 31 Mar 2029
- Last update posted
- 19 Feb 2026
- Registered enrollment
- 74
- Registry id
- NCT03929601
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.